18-36298120-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001281740.3(FHOD3):c.165+120C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.348 in 875,096 control chromosomes in the GnomAD database, including 59,418 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.30 ( 8160 hom., cov: 31)
Exomes 𝑓: 0.36 ( 51258 hom. )
Consequence
FHOD3
NM_001281740.3 intron
NM_001281740.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 18-36298120-C-T is Benign according to our data. Variant chr18-36298120-C-T is described in ClinVar as [Benign]. Clinvar id is 1233999.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.394 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHOD3 | ENST00000590592.6 | c.165+120C>T | intron_variant | Intron 1 of 28 | 1 | NM_001281740.3 | ENSP00000466937.1 | |||
FHOD3 | ENST00000257209.8 | c.165+120C>T | intron_variant | Intron 1 of 24 | 1 | ENSP00000257209.3 | ||||
FHOD3 | ENST00000359247.8 | c.165+120C>T | intron_variant | Intron 1 of 23 | 1 | ENSP00000352186.3 | ||||
FHOD3 | ENST00000589114.5 | n.284+120C>T | intron_variant | Intron 1 of 13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.305 AC: 46181AN: 151518Hom.: 8156 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
46181
AN:
151518
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.357 AC: 258033AN: 723470Hom.: 51258 AF XY: 0.350 AC XY: 126459AN XY: 361260 show subpopulations
GnomAD4 exome
AF:
AC:
258033
AN:
723470
Hom.:
AF XY:
AC XY:
126459
AN XY:
361260
Gnomad4 AFR exome
AF:
AC:
2415
AN:
14390
Gnomad4 AMR exome
AF:
AC:
2332
AN:
7992
Gnomad4 ASJ exome
AF:
AC:
3103
AN:
13174
Gnomad4 EAS exome
AF:
AC:
16
AN:
24358
Gnomad4 SAS exome
AF:
AC:
5159
AN:
37986
Gnomad4 FIN exome
AF:
AC:
15257
AN:
33748
Gnomad4 NFE exome
AF:
AC:
218594
AN:
556096
Gnomad4 Remaining exome
AF:
AC:
10628
AN:
33376
Heterozygous variant carriers
0
7785
15570
23356
31141
38926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
5640
11280
16920
22560
28200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.305 AC: 46216AN: 151626Hom.: 8160 Cov.: 31 AF XY: 0.299 AC XY: 22127AN XY: 74056 show subpopulations
GnomAD4 genome
AF:
AC:
46216
AN:
151626
Hom.:
Cov.:
31
AF XY:
AC XY:
22127
AN XY:
74056
Gnomad4 AFR
AF:
AC:
0.185643
AN:
0.185643
Gnomad4 AMR
AF:
AC:
0.279175
AN:
0.279175
Gnomad4 ASJ
AF:
AC:
0.237464
AN:
0.237464
Gnomad4 EAS
AF:
AC:
0.00275482
AN:
0.00275482
Gnomad4 SAS
AF:
AC:
0.12391
AN:
0.12391
Gnomad4 FIN
AF:
AC:
0.451766
AN:
0.451766
Gnomad4 NFE
AF:
AC:
0.397969
AN:
0.397969
Gnomad4 OTH
AF:
AC:
0.285308
AN:
0.285308
Heterozygous variant carriers
0
1514
3028
4541
6055
7569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
270
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at